Overview

General Biologics is a protein engineering company with a platform technology that targets therapeutic proteins to red blood cell precursors and mature red blood cells.  This enhances plasma half-life and shields therapeutic proteins from the immune system, and when needed, will activate red blood cell production without side effects.